Stay updated on Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page header now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T02:14:48.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 have been removed.
    Difference
    0.1%
    Check dated 2025-12-23T12:33:20.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision tag updated from v3.2.0 to v3.3.2; no study content or functionality appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:47:27.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Removed the government funding notice stating information may be out of date and directing users to opm.gov for status updates. The core study details remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T17:27:35.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The updates appear to be minor UI refinements (e.g., header spacing and typography) with no changes to core study content, eligibility criteria, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T11:46:44.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    3%
    Check dated 2025-10-05T16:45:39.000Z thumbnail image

Stay in the know with updates to Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Toripalimab+Surufatinib in Advanced Thyroid Cancer Clinical Trial page.